Identification and validation of bioactive small molecule target through phenotypic screening.

Area of Science:

• Drug Discovery
• Chemical Biology
• Proteomics

Background:

• Systematic screening and target identification are crucial for developing new therapeutic drugs from bioactive small molecules.
• Conventional screening methods may not fully capture the complex cellular effects of small molecules.
• Understanding the holistic impact of small molecules on cellular mechanisms is essential for drug development.

Purpose of the Study:

• To introduce a novel approach combining phenotypic screening with multi-omics-based target identification and validation (MOTIV).
• To demonstrate the effectiveness of this integrated strategy for identifying bioactive small molecules and their protein targets.
• To elucidate the cellular mechanisms underlying the effects of small molecules.

Main Methods:

• Phenotypic screening to observe the visual effects of bioactive small molecules at the cellular or organism level.
• Multi-omics-based target identification and validation (MOTIV) using chemical genomics and proteomics.
• Network analysis and validation of identified target protein candidates.

Main Results:

• Phenotypic screening provides a systems-level view of small molecule effects.
• MOTIV successfully identifies potential target proteins for bioactive small molecules.
• Network analysis and validation confirm biologically relevant targets and cellular mechanisms.

Conclusions:

• The combination of phenotypic screening and MOTIV offers an effective strategy for bioactive small molecule discovery.
• This integrated approach facilitates the identification of novel therapeutic drug candidates.
• It enables a comprehensive understanding of target proteins and their associated cellular mechanisms.